Troponin Elevation in Patients Undergoing Percutaneous Hepatic Perfusion for Metastatic Uveal Melanoma.
Sanjay ChandrasekharMatthew PerezZurain NiazJahanzaib EkramNeelam LalSarah KolyBiwei CaoJonathan S ZagerMohammed E AlomarPublished in: Cancer control : journal of the Moffitt Cancer Center (2024)
Percutaneous Hepatic Perfusion is safe and associated with a transient, asymptomatic troponin elevation peri-operatively without major adverse cardiac events at 90 days. The observed troponin elevation is likely secondary to coronary demand-supply mismatch related to procedural hemodynamic shifts, hypotension, and anemia.
Keyphrases
- patients undergoing
- minimally invasive
- ultrasound guided
- squamous cell carcinoma
- coronary artery disease
- contrast enhanced
- radiofrequency ablation
- small cell lung cancer
- coronary artery
- chronic kidney disease
- left ventricular
- cerebral ischemia
- atrial fibrillation
- blood brain barrier
- aortic stenosis
- transcatheter aortic valve replacement
- skin cancer
- adverse drug
- brain injury
- electronic health record